Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 30.05
+0.05 (0.17%)
Nov 13, 2026, 1:30 PM CST
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 6.06 billion as of November 13, 2026. It is the 20,968th most valuable company in the world and the 957th biggest in Taiwan. Its market cap has increased by 1.93% in one year.
Market Cap
6.06B
Enterprise Value
6.78B
Revenue
3.45B
Global Rank
Country Rank
#957 Taiwan
PE Ratio
17.31
ChartMarket Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 6.06B, an increase of 438.33%. That is a compound annual growth rate of 7.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 6.06B | 4.44% |
| Dec 31, 2025 | 5.80B | 2.64% |
| Dec 31, 2024 | 5.65B | -0.75% |
| Dec 29, 2023 | 5.69B | 2.41% |
| Dec 30, 2022 | 5.56B | 14.71% |
| Dec 30, 2021 | 4.85B | -6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 8.04B |
| PharmaEngine | 7.61B |
| Locus Cell | 7.57B |
| Tanvex BioPharma | 7.43B |
| Adimmune | 7.04B |
| Acepodia | 6.85B |
| AnnJi Pharmaceutical | 6.57B |
| Savior Lifetec | 6.30B |